CRSP
CRISPR Therapeutics AG
NASDAQ · Healthcare · Biotechnology · CH
$51.78
+3.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 60.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.05x
- Price / sales
- 199.52x
- Price / cash flow
- -13.41x
Enterprise value
- Enterprise value
- $3.5B
- EV / sales
- 140.22x
- EV / EBITDA
- -7.68x
- EV / EBIT
- -6.66x
- Market cap
- $5.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026